Advertisement

Factors Regulating Ligand Binding to 5-Hydroxytryptamine Receptors in Rat Brain

  • Tomio Segawa
  • Yasuyuki Nomura
  • Hiroaki Nishio
  • Jun-ichi Taguchi
  • Mutsuko Fujita
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 160)

Abstract

Several factors have been known to regulate neurotransmitter receptor binding to central nervous system (CNS) but so far little is known about the factors which modify 5-hydroxytryptamine (5-HT) binding properties. Recently, in the course of 5-HT binding studies, it was found that ascorbic acid (AA), Mn2+, and HCO 3 could modify ligand binding to central 5-HT receptors in rat.

Keywords

Ascorbic Acid Adenylate Cyclase Guanine Nucleotide Iodoacetic Acid Lysergic Acid Diethylamide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. J. Peroutka and S. H. Snyder, Multiple serotonin receptors:Differential binding of 3H]serotonin,3H]lysergic aciddiethylamide and 3H]spiroperidol, Mol. Pharmacol. 16: 687 (1979).Google Scholar
  2. 2.
    H. Ohkuma, N. Ohishi, and K. Yagi, Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction, Anal.Biochem. 95: 351 (1979).CrossRefGoogle Scholar
  3. 3.
    O. H. Lowry, H. J. Rosebrough, A. L. Farr, and R.. Randall, Protein measurement with the Folin phenol eagent, J. Biol. Chem. 193: 265 (1951)Google Scholar
  4. 4.
    L. G. Abood and F. Takeda, Enhancement of stereospecific opiate binding to neural membranes by phosphatidyl serine, European J. Pharmacol. 39: 71 (1976).Google Scholar
  5. 5.
    M. Rodbell, M. C. Lin, Y. Salomon, C. Londos, J. P. Harwood, B. R. Martin, M. Rendell, and N. Berman, Role of adenine and guanine nucleotides in activity and response of adenylate cyclase system, Adv. Cyclic Nucleotide Res. 5: 3 (1975).Google Scholar
  6. 6.
    J. Wolff and G. H. Cook, Activity of thyroid membrane adenylate cyclase by purine nucleotides, J. Biol. Chem. 248: 350 (1973).Google Scholar
  7. 7.
    A. J. Blume and C. J. Foster, Neuroblastoma adenylate cyclase: Role of 2-chloradenoisine, prostaglandin E and guanine nucleotides in regulation of activity, J. Biol. Chem. 251: 3399 (1976).Google Scholar
  8. 8.
    A. Levitzki, N. Sevilla, and M. L. Steer, The regulatory control of ß-adrenergic dependent adenylate cyclase, J. Supramol. Struct. 4: 405 (1976).CrossRefGoogle Scholar
  9. 9.
    F. Pecker and J. Hanoue, Activity of epinephrine-sensitive adenylate cyclase in rat liver by cytosolic protein nucleotide complex, J. Biol. Chem. 252: 2784 (1977).Google Scholar
  10. 10.
    M. Lucas and J. Bockaert, Use ofdihydroalprenolol to study ß-adrenergic adenylate cyclase coupling in glioma cells: Role of 5′-guanylimidodiphosphate, Mol. Pharmacol. 13: 314 (1977).Google Scholar
  11. 11.
    H. Yamamura and M. Rodbell, Hydroxybenzylpindolol and hydroxybenzylpropranolol: Partial ß-adrenergic agonists of adenylate cyclase in rat adipocytes, Mol. Pharmacol. 12: 693 (1976).Google Scholar
  12. 12.
    S. R. Childers and S. H. Snyder, Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interaction, J. Neurochem. 34: 583 (1980).CrossRefGoogle Scholar
  13. 13.
    F. M. Leslie, C. E. Dunlap III, and B. M. Cox, Ascorbate decreases ligand binding to neurotransmitter receptors, J. Neurochem. 34: 219 (1980).CrossRefGoogle Scholar
  14. 14.
    S. 0. Kayaalp and N. H. Neff, Differentiation by ascorbic acid of dopamine agonist and antagonist binding sites in striatum, Life Sci. 26: 1837 (1980).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Tomio Segawa
    • 1
  • Yasuyuki Nomura
    • 1
  • Hiroaki Nishio
    • 1
  • Jun-ichi Taguchi
    • 1
  • Mutsuko Fujita
    • 1
  1. 1.Department of Pharmacology, Institute of Pharmaceutical SciencesHiroshima University School of MedicineHiroshimaJapan

Personalised recommendations